Defunct Company
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
13,164
NCT00877448
A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001)
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jun 30, 2009
Completion: Nov 30, 2009
NCT01010737
A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001) Injected to Elderly Volunteers
Start: Sep 30, 2009
Completion: Mar 31, 2010
NCT01146119
Further Investigation of an Intramuscular Influenza Vaccine (Multimeric-001)
Phase: Phase 2
Start: Jul 31, 2010
Completion: Jun 30, 2011
NCT01419925
A Study to Assess the Safety and Immunogenicity of M-001 Influenza Vaccine as a Primer to TIV in Elderly Volunteers
Start: Aug 31, 2011
Completion: Jan 31, 2012
NCT02293317
Phase II Study to Assess Safety & Immunogenicity of Multimeric-001 Influenza Vaccine, Followed by TIV
Start: Nov 30, 2014
Completion: Jun 30, 2015
NCT02691130
Assess the Safety and Immunogenicity of M-001 as A Standalone Influenza Vaccine and as A H5N1 Vaccine Primer in Adults
Start: Nov 30, 2015
Completion: Jan 31, 2017
NCT03450915
A Pivotal Trial to Assess the Safety and Clinical Efficacy of the M-001 as a Standalone Universal Flu Vaccine
Phase: Phase 3
Start: Aug 1, 2018
Completion: Oct 23, 2020